TrialBreast cancer research and treatment2012

A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer.

G Somlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.